Manufacturers Increase Drug Prices Twice as Fast During Drug Shortages
Prices of prescription drugs in short supply between 2015 and 2016 were found to increase more than twice as quickly as they would have in the absence of a shortage.
All articles by Laurel Ranger
Clinicians Raise Concerns About “Precision” Public Health in the Era of Genomics
Although the trend of “precision public health” promises to change the landscape of the public health field, concerns surrounding the scientific, practical, and ethical implications have cast a shadow over the innovation.
Clinical Practice Guidelines Establish Norms of Practice But Must Reduce Risk for Bias
Clinical practice guidelines are an important part of medical practice, but scarce funding for updates and the risk for bias have raised challenges.
Bioethics Concerns Should Be a Key Element in mHealth Technology Development
With the ubiquitous availability of digital technology such as smartphones, smart watches, health-related apps, and patient monitoring devices, the era of mHealth is upon us.
Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
Researchers conducted a double-blind crossover study in adults with treatment-resistant depression to determine the involvement of the opioid system in ketamine’s antidepressant effects.
Major Barriers to Useful Risk Prediction Must Be Overcome to Reach the Full Potential of Big Data
The promise of big data and predictive analytics to provide new predictive models and improve the practice of medicine must overcome 4 major hurdles before it can be considered of clinical value.
The Challenge of Compassion in Modern Healthcare Settings
A providers’ capacity to feel compassion is affected in part by the practice environment.
Prioritizing Rest in Hospital Settings: Poor Sleep Increases Costs, Complications, and Mortality
Study results serve as an important impetus for physicians, nurses, hospital administrators, and others involved in the care of hospitalized patients to optimize sleep in the hospital setting.
FDA Taps Social Media to Identify and Assess Emerging Drug Abuse Threats
The FDA continues to battle the nation’s opioid problem even as it looks to detect and prevent the next threat.
Marijuana’s Uncertain Status: Closing the Gap Between State and Federal Policies
Senator Elizabeth Warren introduced a bipartisan bill in June 2018 (S.3032) that would exempt most marijuana-related activities from the Controlled Substances Act when they are allowed under state or tribal law.
Next post in Regulatory Issues
